• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Wearable infusion device maker Bexson Biomedical appoints SVP of drug delivery

March 3, 2021 By Sean Whooley

Bexson BiomedicalBexson Biomedical announced today that it appointed Sheldon Moberg as its new senior vice president of drug delivery.

Santa Barbara, Calif.–based Bexson said in a news release that Moberg will lead the development of its drug delivery technologies, starting with a wearable infusion device for its BB106 therapy developed in partnership with Stevanato Group.

The lead indication for Bexson’s technology is for treating moderate to severe acute pain with its proprietary ketamine formulation, BB106, and a subcutaneous wearable device — the SG EZ-be Pod, a small, wearable and programmable infusion device customized through an agreement with Stevanato Group.

Moberg is slated to work on developing the lead product while expanding Bexson’s drug delivery program to develop solutions for other drug therapies in which subcutaneous delivery and dosing control offer distinct advantages.

“After many years in this field, I look forward to joining the Bexson team as they ramp up some truly groundbreaking device and delivery programs for pain management and other indications,” Moberg said in the release. “I believe Bexson will be able to create viable solutions that not only have the potential for difficult to treat conditions, but that can also help in preventing them.”

The veteran of more than 30 years in medical device innovation most recently served as head of advanced device technologies and innovation at Amgen. Over the course of his career, he has been granted over 130 U.S. patents and his work has led to over $1.5 billion in revenue, Bexson said.

“Sheldon has a history of developing patient-centered devices that dramatically improve lives. With his help, the technology we’re developing with Stevanato Group has great potential for application beyond our non-opioid BB106 therapy for pain management,” Bexson Biomedical co-founder & CSO Jeffrey Becker said. “Sheldon’s expertise and innovations are allowing us to explore additional psychedelic and non-psychedelic therapies to help address treatment-resistant conditions.”

Filed Under: Auto-injectors, Business/Financial News, Drug-Device Combinations, Featured, Pain Management, Pharmaceuticals Tagged With: Bexson Biomedical, Personnel, Personnel Moves, wearables

IN CASE YOU MISSED IT

  • Dexcom updates CGM receiver recall that led to serious adverse events
  • Abbott reports momentum with Libre CGM business as new dual sensor will ‘accelerate’ growth
  • Johnson & Johnson wins FDA priority review for drug delivery system
  • Glucose monitoring company LifeScan files chapter 11 to reduce debt
  • Medtronic enrolls first patient in study for Onyx liquid embolic system

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS